MarketPulse

clinical validation

5 articles
BenzingaBenzinga··Usa News Group

Medtech Giants Race to Acquire AI Diagnostics as Hospital Demand Surges

Medtech giants aggressively acquiring AI diagnostic platforms as hospital adoption surges. $2.20B market projected by 2026 with 34.8% growth through 2033.
MDTDHRDXCMPROFAI diagnosticsclinical validation
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Agora Partners With thymia to Embed Real-Time Voice Health Intelligence

Agora integrates thymia's voice biomarker technology into its platform to detect stress and fatigue signals across healthcare, automotive, and workplace sectors.
APIconversational AIbiomarkers
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Beauty Health Rebrands as SkinHealth Systems, Pivoting to Clinical Medical Aesthetics

Beauty Health rebrands to SkinHealth Systems Inc., pivoting toward clinical medical aesthetics with 36,000+ global devices and Hydrafacial flagship.
SKINHydrafacialmedical aesthetics
BenzingaBenzinga··Usa News Group

Five AI Leaders Transform Cardiac Diagnostics, Expanding Access to Remote Communities

Five AI companies advance decentralized cardiac diagnostics through partnerships expanding access to remote communities and strengthening clinical evidence bases.
GEHCHTFLBEATBEATWHYPR+1clinical validationcardiovascular disease
GlobeNewswire Inc.GlobeNewswire Inc.··Castle Biosciences, Inc.

Castle Biosciences Test Predicts JAK Inhibitor Response in Atopic Dermatitis

Castle Biosciences' AdvanceAD-Tx test predicts which atopic dermatitis patients will respond to JAK inhibitors, showing 5.5x better outcomes for identified responders versus alternative treatments.
CSTLpersonalized medicineatopic dermatitis